Onyia Jude
- SEC CIK
- 0001894425
In the past year, 2 open-market sale filings worth $3.47M and no purchases.
Current role at each company
- NBIX Neurocrine Biosciences IncChief Scientific Officeras of Sep 15, 2026
- VYGR Voyager Therapeutics, Inc.Directoras of Jun 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.47M
- 2 filings
- Net
- −$3.47M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Onyia Jude as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NBIX Neurocrine Biosciences Inc
Chief Scientific Officer14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Onyia JudeChief Scientific Officer | SSale | −11.0K | $160.25 | −$1.76M | −29.9%25.8K after | 10b5-1 |
| May 29, 2026 (view filing) | May 27 | 2 days | Onyia JudeChief Scientific Officer | SSale | −11.0K | $155.53 | −$1.71M | −29.9%25.8K after | 10b5-1 |
| Jul 11, 2025 (view filing) | Jul 9 | 2 days | Onyia JudeChief Scientific Officer | SSale | −59.8K | $130.46 | −$7.80M | −76.6%18.3K after | 10b5-1 |
| Jul 7, 2025 (view filing) | Jul 2 | 5 days | Onyia JudeChief Scientific Officer | SSale | −20.4K | $130.13 | −$2.65M | −52.7%18.3K after | 10b5-1 |
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | Onyia JudeChief Scientific Officer | SSale | −2.88K | $116.79 | −$336.2K | −13.7%18.1K after | 2 lots10b5-1 |
| Feb 4, 2025 (view filing) | Jan 31 | 4 days | Onyia JudeChief Scientific Officer | SSale | −126 | $152.97 | −$19.3K | −0.8%15.6K after | 10b5-1 |
| Dec 3, 2024 (view filing) | Nov 29 | 4 days | Onyia JudeChief Scientific Officer | SSale | −2.33K | $126.29 | −$294.4K | −13.1%15.4K after | 10b5-1 |
| Feb 15, 2024 (view filing) | Feb 13 | 2 days | Onyia JudeChief Scientific Officer | SSale | −1.43K | $132.94 | −$190.4K | −9.8%13.1K after | 10b5-1 |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Onyia JudeChief Scientific Officer | SSale | −126 | $141.94 | −$17.9K | −1.1%11.8K after | 10b5-1 |
| Dec 1, 2023 (view filing) | Nov 29 | 2 days | Onyia JudeChief Scientific Officer | SSale | −2.33K | $113.57 | −$264.7K | −16.6%11.7K after | 10b5-1 |